1 / 5

Medical uses of ATGAM Injection

ATGAM is introduced to manage the allograft rejection in the recipients of renal transplant; when used along with conventional therapy at the moment of rejection this agent increases the frequency of the resolution of the acute rejection episode.

shipra2
Download Presentation

Medical uses of ATGAM Injection

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MEDICAL USES OF ATGAM INJECTION

  2. ATGAM is approved to treat moderate/severe aplastic anemia in recipients unsuitable for the bone marrowtransplantation. The usefulness of atgam injection has not been shown in recipients with aplastic anemia who are suitable candidates for bone marrow transplantation or in recipients with aplastic anemia secondary to neoplastic disease, Fanconi's syndrome, storage disease, myelofibrosis, or in patients known to have been exposed to radiation or myelotoxic agents. Approval: The ATGAM injection is approved in the US (UnitedStates): In order to manage moderate/severe aplastic anemia (a blood disorder that damages stemcells). In order to prevent the body from rejecting a kidneytransplant.

  3. Dosage ATGAM comes in the form of injection. It is intended for intravenous use only withconcomitant immunosuppressants. While repeat courses of ATGAM, observe the recipients for signs of allergicreactions. The recommended dose of ATG injection for Renal Allograft Recipients is 10 to 15 mg per kg daily administered intravenously for 2 weeks. The supplementary alternate day therapy up toa total of 21 doses can beadministered. The recommended dose for Aplastic Anemia (Moderate to Severe) is 10 to 20 mg per kgdaily administered intravenously for 8 to 14 days. The supplementary alternate day therapy up to a total of twenty one doses can begiven.

  4. SIDEEFFECTS The most commonly reported side effects due to Anti-thymocyte Globulininclude: pyrexia chills rash leukopenia arthralgia thrombocytopenia

  5. PRICE ANDCOST You can buyanti thymocyte globulin from Indiaonline authentically from The Indian Pharma if this product is not available or has not been approved in your homecountry.

More Related